InvestorsHub Logo
Followers 8
Posts 1435
Boards Moderated 0
Alias Born 07/26/2016

Re: zombywolf post# 31342

Wednesday, 11/22/2017 8:25:11 AM

Wednesday, November 22, 2017 8:25:11 AM

Post# of 72993
You are correct, but are guessing on the percentage. We may find out when the next financial Q is released. Either way, it's positive revenue which is what it's all about with a new and expanding company. They are also starting production on the CBD product line which IMO will bring in nice revenue. GLTA $$$ VDRM $$$

"The Company will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for “Aqueous Topical Applications” for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) “Intellectual Property Portfolio” in 2018."